Innate immunity, local inflammation, and degenerative disease

¹Kinsmen Laboratory of Neurological Research at the University of British Columbia, Vancouver, BC, V6T 1Z3, Canada. mcgeerpl@interchange.ubc.ca

Science of Aging Knowledge Environment : SAGE KE

|November 7, 2003

Summary

Alzheimer's disease (AD) brain lesions involve inflammation and complement system self-attack, not typical autoimmunity. Targeting these inflammatory pathways, like the complement system, may offer new therapeutic strategies for AD.

Area of Science:

Neuroscience
Immunology
Pathology

Background:

Alzheimer's disease (AD) brain lesions (neurofibrillary tangles, senile plaques) feature inflammatory mediators.
These mediators, including complement proteins and cytokines, are produced by resident brain cells like neurons.
Inflammation exacerbates neuronal loss in AD, distinct from typical T-cell mediated autoimmunity.

Purpose of the Study:

To define the inflammatory mechanisms in Alzheimer's disease (AD) brain lesions.
To differentiate AD-associated inflammation from classical autoimmunity.
To explore potential therapeutic targets for AD based on inflammatory pathways.

Main Methods:

Analysis of inflammatory mediators in AD brain lesions.
Investigation of immune system component involvement (e.g., complement system).
Comparison of AD inflammation with atherosclerotic plaques and classical autoimmunity.

Main Results:

AD lesions exhibit a broad spectrum of inflammatory mediators produced by neurons.
Evidence of complement system self-attack within AD lesions, termed autotoxicity.
Absence of significant T cell infiltration and antibodies in AD lesions.

Conclusions:

Alzheimer's disease involves a unique inflammatory autotoxicity, not classical autoimmunity.
Inflammation, particularly complement system activation, significantly contributes to AD pathogenesis.
Targeting inflammatory mechanisms, especially the complement system, presents a promising therapeutic avenue for AD.

Related Experiment Videos

Innate immunity, local inflammation, and degenerative disease

Related Concept Videos

Saliva Diagnosis as a Disease Predictor.

Application of multisegment injection on quantification of creatinine and standard addition analysis of urinary 5-hydroxyindoleacetic acid simultaneously with creatinine normalization.

Conquering Alzheimer's Disease by Self Treatment.

Alzheimer's Disease Can Be Spared by Nonsteroidal Anti-Inflammatory Drugs.

Biological Imaging with Medium-Sensitive Bichromatic Flexible Fluorescent Dyes.

Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly.

I come not to bury SAGE KE but to appraise It.

Targeting the role of the endosome in the pathophysiology of Alzheimer's disease: a strategy for treatment.

From bedside to bench: does mental and physical activity promote cognitive vitality in late life?

The unusual genetics of human longevity.

A work in progress: the metabolic syndrome.

WRN's tenth anniversary.

The why, what, who and when of B cell depletion in systemic lupus erythematosus: Biological rationale, patient stratification and evolving therapeutic modalities.

Immune checkpoint inhibitor-associated severe hyponatremia: evidence mapping of SIADH-like phenotypes and endocrine immune-related adverse events.

Immune Checkpoint Inhibitor-Associated Hemophagocytic Lymphohistiocytosis: Clinical Presentation and Outcomes in Three Patients.

Giant cell arteritis during risankizumab therapy: a possible paradoxical reaction to IL-23 inhibition.

Small Intestinal Extranodal Marginal Zone Lymphoma Mimicking Crohn's Disease.

A Pancreas Out of Place: Acute Interstitial Pancreatitis Caused by Pancreatic Herniation in a Type IV Paraesophageal Hernia.

Related Experiment Videos

Innate immunity, local inflammation, and degenerative disease

Area of Science:

Background:

Purpose of the Study:

Main Methods:

Main Results:

Conclusions:

Related Concept Videos

Related Articles